Treatment of chronic osteomyelitis with multidose oritavancin: A case series and literature review.
Sign Up to like & getrecommendations! Published in 2019 at "International journal of antimicrobial agents"
DOI: 10.1016/j.ijantimicag.2018.11.023
Abstract: Osteomyelitis remains difficult to treat, typically requiring a prolonged course of intravenous (i.v.) antibiotics. The optimal route and duration of antibiotics remains ill-defined due to limited prospective clinical trials. Oritavancin is a long-acting, semisynthetic lipoglycopeptide… read more here.
Keywords: chronic osteomyelitis; osteomyelitis multidose; multidose oritavancin; treatment chronic ... See more keywords